Balanced news tone
News Sentiment
IDX sentiment intelligence
Integral Diagnostics Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
+2.0% over one week, +1.0% over four weeks, trend inactive, and near fair-value range.
Qiagen stock reflects steady diagnostics demand as earnings and cash flow support investment cycle
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Qiagen stock reflects steady diagnostics demand as earnings and cash flow support investment cycle
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 19:43
- Source
- ad-hoc-news.de
Qiagen stock holds steady as diagnostics demand shapes long term outlook
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 14 Jul 2026 09:00
- Source
- ad-hoc-news.de
Qiagen stock holds steady as diagnostics demand supports long-term growth
- Tone
- Positive 66/100
- Event
- Macro sensitivity
- Published
- 13 Jul 2026 06:08
- Source
- ad-hoc-news.de
Qiagen stock reflects steady diagnostics demand as investors weigh long-term growth drivers
- Tone
- Positive 66/100
- Event
- Macro sensitivity
- Published
- 12 Jul 2026 12:19
- Source
- ad-hoc-news.de
Roche stock holds steady as pharma giant leans on diagnostics and oncology strength
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jul 2026 08:31
- Source
- ad-hoc-news.de
Labcorp stock holds its business focus. Clinical diagnostics remain the core.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 09:51
- Source
- ad-hoc-news.de
Quest Diagnostics (DGX) Stock Analysis: Revenue Growth and Dividend Yield Capture Investor Attention
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 06 Jul 2026 09:16
- Source
- DirectorsTalk Interviews
Qiagen N.V. highlights molecular diagnostics growth as investors eye global health demand
- Tone
- Positive 66/100
- Event
- Macro sensitivity
- Published
- 06 Jul 2026 06:41
- Source
- ad-hoc-news.de
Integral Diagnostics Issues 67,226 Ordinary Shares to CEO and CFO Following Stage 2 Capital Merger Performance Rights Vesting
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 01 Jul 2026 07:52
- Source
- Kalkine
Independent Non-Executive Chairman of Integral Diagnostics James Hall Buys 23% More Shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 07:00
- Source
- simplywall.st
Qiagen N.V. updates earnings calendar, shares tracked against diagnostics peers
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 05:11
- Source
- ad-hoc-news.de
Integral Diagnostics Director James Hall Buys 51,300 Shares on Market at $1.963 Each
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Kalkine
Quest Diagnostics Stock - Analyst targets, sector review and weekly recap
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 19 Jun 2026 16:09
- Source
- ad-hoc-news.de
Integral Diagnostics to Release 178,146 Escrowed Shares on 1 July 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 07:00
- Source
- Kalkine
Integral Diagnostics Upgraded: Risk/Reward Improves, But Not Enough
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- thebull.com.au
Can Integral Diagnostics (ASX:IDX) Benefit From Australia’s Growing Healthcare Demand?
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 26 May 2026 07:00
- Source
- Kalkine
Could Integral Diagnostics ASX 300 Stay In Focus?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- Kalkine Media
Integral Diagnostics And 2 Other ASX Stocks That May Be Trading Below Estimated Value
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 May 2026 07:00
- Source
- Market source
Integral Diagnostics Ltd (ASX:IDX): Medical Imaging Leader Succumbs to Major Structural Breakdown
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- Kalkine
Integral Diagnostics H1 2026 Thin 1.8% Net Margin Tests Bullish Growth Narratives
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 24 Feb 2026 08:00
- Source
- simplywall.st
The past five-year earnings decline for Integral Diagnostics (ASX:IDX) likely explains shareholders long-term losses
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 26 Aug 2025 07:00
- Source
- simplywall.st
Checking the Pulse of Integral Diagnostics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2024 07:00
- Source
- intelligentinvestor.com.au
IDX ASX: Integral Diagnostics dealmaking creates $1b diagnostics giant
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2024 07:00
- Source
- AFR
Integral Diagnostics Ltd Revenue Breakdown – ASX:IDX
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 19 Aug 2023 02:26
- Source
- TradingView